BerandaGRAL • NASDAQ
add
Grail Inc
Tutup sebelumnya
$17,52
Rentang tahun
$12,33 - $21,47
Kapitalisasi pasar
549,56Â jt USD
Volume Rata-Rata
605,16Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 28,65Â jt | 38,27% |
Biaya operasional | 175,74Â jt | -12,27% |
Laba bersih | -125,69Â jt | 85,90% |
Margin laba bersih | -438,67 | 89,80% |
Penghasilan per saham | -3,50 | — |
EBITDA | -125,27Â jt | 18,72% |
Tarif pajak efektif | 27,10% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 853,55 jt | — |
Total aset | 3,12 M | — |
Total liabilitas | 530,32 jt | — |
Total ekuitas | 2,59 M | — |
Saham yang beredar | 33,60 jt | — |
Harga terhadap nilai buku | 0,22 | — |
Tingkat pengembalian aset | -12,88% | — |
Tingkat pengembalian modal | -15,14% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -125,69Â jt | 85,90% |
Kas dari operasi | -104,58Â jt | 33,60% |
Kas dari investasi | -971,00Â rb | 68,36% |
Kas dari pembiayaan | 0,00 | -100,00% |
Perubahan kas bersih | -105,29Â jt | -21,33% |
Arus kas bebas | -36,90 jt | — |
Tentang
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms.
Grail was spun-out from Illumina on June 24, 2024.
Their liquid biopsy was launched in June 2021 and is called the Galleri test. Promoted as groundbreaking, the test performed poorly in testing and Grail has subsequently faced discontent and legal action from investors claiming they have been misled about the test's potential. Wikipedia
Didirikan
2015
Kantor pusat
Situs
Karyawan
1.170
